Results 221 to 230 of about 627,574 (286)
ESC Heart Failure, EarlyView.Abstract Aims There are limited tools to predict long‐term mortality among patients hospitalized with acute heart failure (AHF) in China. This study aimed to develop and validate a model to predict long‐term mortality risk among patients who were hospitalized with AHF and discharged alive.
Wei Wang +8 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims This study aimed to identify factors associated with frailty in heart failure (HF) patients, focusing on demographic, biochemical and health‐related variables. It also explored the correlation between frailty and comorbidities such as malnutrition, cognitive impairment and depression, assessing how these factors interact to influence ...
Marta Wleklik +6 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Describe patient characteristics, treatment patterns, clinical outcomes, healthcare resource utilization (HCRU) and medical costs associated with patients who were diagnosed with obstructive hypertrophic cardiomyopathy (HCM) in clinical practice in England.
Faizel Osman +9 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Cardiogenic shock (CS) is the deadliest manifestation of acute heart failure, with persistently high mortality rates and a lack of recent therapeutic breakthroughs. Accurate risk prediction is crucial in clinical decision‐making and the design of future clinical trials.
Elina Hynninen +14 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL.
Matteo Pagnesi +21 more
wiley +1 more source
Elements of effective palliative care interventions in advanced heart failure: A narrative review
ESC Heart Failure, EarlyView.Abstract People with advanced heart failure experience significant biopsychosocial needs and have a poor prognosis. International guidelines have called for integrating palliative care in heart failure management. This review explores the elements of effective palliative care interventions in advanced heart failure.
Peter Allcroft +4 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Information about current use of finerenone in patients with heart failure (HF) finerenone in clinical practice is scarce, and its effectiveness in clinical practice in patients is scarce. We aim to assess both the baseline clinical profile and prognostic role of finerenone in patients with HF, irrespective of ejection fraction.
Gonzalo Luis Alonso Salinas +32 more
wiley +1 more source
Current and novel biomarkers in cardiogenic shock
European Journal of Heart Failure, EarlyView.A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko +5 more
wiley +1 more source
European Journal of Heart Failure, EarlyView.Association of a remote monitoring programme (RMP) with all‐cause mortality and hospitalization in heart failure (HF) patients. COPD, chronic obstructive pulmonary oedema; HR, hazard ratio; ICU, intensive care unit; LTI, long‐term illness; RR, rate ratio; SoC, standard of care.
Nicolas Girerd +12 more
wiley +1 more source
European Journal of Heart Failure, EarlyView.Among high‐risk patients with T2D, new oral loop diuretic intensification was frequent and portended adverse prognostic significance. Treatment with canagliflozin significantly reduced the need for loop diuretic intensification. ABSTRACT Aims The sodium–glucose cotransporter 2 inhibitor canagliflozin reduces the risk of heart failure (HF ...
Safia Chatur +11 more
wiley +1 more source